USA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 ...

In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

Tirzepatide was associated with significant reductions in weight primarily due to fat mass loss while preserving lean mass in obesity.

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online ...

A new study funded by Eli Lilly reports that people without diabetes can lose up to 13% of their starting weight in 6 months ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...

Lexaria Bioscience (LEXX) announced pharmacokinetic results from Human Study #3 or GLP-1-H24-3, comparing an oral version of ...